Amgen Inc. buy Scotiabank
Start price
13.11.25
/
50%
€292.00
Target price
13.11.26
€332.22
Performance (%)
14.20%
Price
27.02.26
€328.55
Summary
This prediction is currently active. The BUY prediction by Scotiabank currently has a performance of 14.20%. A total of €4.90 was paid as dividends for this prediction. This prediction currently runs until 13.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.334% | 3.334% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Scotiabank for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat